Optimal antiarrhythmic drug therapy for electrical storm  

作　　者：Dan Sorajja Thomas M.Munger Win-Kuang Shen 

机构地区：[1]Division of Cardiovascular Diseases,Mayo Clinic Arizona

出　　处：《The Journal of Biomedical Research》2015年第1期20-34,共15页生物医学研究杂志（英文版）

摘　　要：Electrical storm, defined as 3 or more separate episodes of ventricular tachycardia or ventricular fibrillation within 24 hours, carries significant morbidity and mortality. These unstable ventricular arrhythmias have been described with a variety of conditions including ischemic heart disease, structural heart disease, and genetic conditions. While implantable cardioverter defibrillator implantation and ablation may be indicated and required, anti- arrhythmic medication remains an important adjunctive therapy for these persons.Electrical storm, defined as 3 or more separate episodes of ventricular tachycardia or ventricular fibrillation within 24 hours, carries significant morbidity and mortality. These unstable ventricular arrhythmias have been described with a variety of conditions including ischemic heart disease, structural heart disease, and genetic conditions. While implantable cardioverter defibrillator implantation and ablation may be indicated and required, anti- arrhythmic medication remains an important adjunctive therapy for these persons.

关 键 词：antiarrhythmic medication electrical storm ventricular tachycardia ventricular fibrillation 

分 类 号：R541.7[医药卫生—心血管疾病]